---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-003221"
form_type: "8-K"
ticker: "ENTA"
cik: "0001177648"
company_name: "ENANTA PHARMACEUTICALS INC"
filed_at: "2022-03-09T23:59:59+00:00"
generated_at: "2026-06-27T00:18:38.574626+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Enanta Pharmaceuticals amends equity plan, adds 1.05M shares for issuance

## Summary
- Stockholders approved amendment to 2019 Equity Incentive Plan at March 3, 2022 annual meeting.
- Increase of 1,050,000 shares of common stock reserved for issuance under the plan.
- Plan as amended filed as Exhibit 10.1.

## SEC filing metadata
- accession: 0000950170-22-003221
- form_type: 8-K
- ticker: ENTA
- cik: 0001177648
- company_name: ENANTA PHARMACEUTICALS INC
- filed_at: 2022-03-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1177648/000095017022003221/0000950170-22-003221-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1177648/000095017022003221/enta-20220303.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-003221
- JSON: https://secwatch.observer/filing/0000950170-22-003221.json
- Plain text: https://secwatch.observer/filing/0000950170-22-003221.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.